Signed declaration of manufacture (for each manufacturing site, if relevant) in accordance with the dossier and according to GMP rules (as described in Annex 3a) (or, if the substance is not a drug substance, a suitable quality assurance system, specifying which rules/guidelines/standards are followed, as described in Annex 3b). Signed declaration of willingness to be inspected (for each manufacturing site, if relevant). This also applies for holders when different from manufacturers (as described in Annex 4). Signed declaration on use or non-use of materials of human or animal origin including TSE risk materials (not to be submitted in case of an application for a TSE certificate) (as described in Annex 5)